Sofosbuvir/ledipasvir cures nearly all genotype 1 HCV for people with HIV co-infection
Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapy
Truvada PrEP use rising in United States, especially among men
One third of TB cases in Eastern European HIV clinic survey multi-drug resistant
Australia performs best in HIV treatment cascade – 62% with undetectable viral load
Generic antiretrovirals could save NHS £1.25 billion over 5 years, study finds
Efavirenz compromises hormonal contraceptive implant
Do emtricitabine and lamivudine have similar virological efficacy when used in first-line HIV therapy?
